Magnitude and time course of platelet inhibition with Aggrenox® and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial-Reference-Cited by-同舟云学术

Magnitude and time course of platelet inhibition with Aggrenox® and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial

Published:2004-09 Issue:3 Volume:499 Page:315-324
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Serebruany Victor L.,Malinin Alex I.,Sane David C.,Jilma Bernd,Takserman Aviv,Atar Dan,Hennekens Charles H.

Publisher

Elsevier BV

Subject

Pharmacology

Reference45 articles.

1. Absolute quantitation of coronary steal induced by intravenous dipyridamole;Akinboboye;J. Am. Coll. Cardiol.,2001

2. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients;BMJ,2002

3. Flow cytometric measurement of platelet function and reticulated platelets;Ault;Ann. N.Y. Acad. Sci.,1993

4. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling;Brass;J. Biol. Chem.,1994

5. Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide;Bult;Eur. J. Pharmacol.,1991

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Layered Tablets: A Novel Oral Solid Dosage Form;Dosage Forms - Innovation and Future Perspectives;2023-04-05

2. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis;Journal of Neurology;2020-06-09

3. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus;Antiviral Research;2018-10

4. Dissolution testing of bilayer tablets: Method development, validation and application in post-marketing quality evaluation;Dissolution Technologies;2017

5. Rationale and strategies for formulation development of oral fixed dose combination drug products;Journal of Pharmaceutical Investigation;2016-11-19